GlassScriptPhysician profile
Jeffrey Thiebaud
NPI 1831727148
$376.67
in general payments reported to CMS, 2019-2025
11 companies · $358 in 2025
The $358 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $18.31 · 2025: $358.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $377.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $376.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $68.35 | 2025 | Kisunla, Jardiance |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $52.51 | 2025 | Caplyta |
| Novo Nordisk INC | $48.40 | 2025 | Rybelsus, Ozempic, Wegovy |
| Viatris Specialty LLC | $40.13 | 2025 | Yupelri |
| Vanda Pharmaceuticals INC. | $37.40 | 2025 | Fanapt |
| Astrazeneca Pharmaceuticals LP | $33.51 | 2024-2025 | Airsupra |
| Exact Sciences Corporation | $22.13 | 2025 | Cologuard Collection Kit |
| Dexcom, INC. | $20.43 | 2025 | Dexcom G6 Transmitter |
| Pfizer INC. | $20.13 | 2025 | |
| Lundbeck LLC | $19.87 | 2025 | Rexulti |
| Verona Pharma, INC. | $13.81 | 2025 | Ohtuvayre |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Thiebaud listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.